The same applies to pioglitazone: pioglitazone was demonstrated to lower MMP9 levels in e.g., murine peritoneal macrophages [51], in lung [52] and breast [53] cancer cells, as well as in serum of atherosclerotic rabbit model [54]. The gene discussed is MMP9; the disease is cancer.